Nasus Pharma Ltd Operating Loss Carryforwards
Nasus Pharma Ltd (NSRX) had Operating Loss Carryforwards of $14.00 million as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-03-25
- 2025-12-31: Operating Loss Carryforwards $14.00M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $14.00M 20-F · filed 2026-03-25 |